AdvaMed®
  • Our Work
    • Key Issues
    • Policy Areas
    • Sectors
    • Emerging Policy & Tariff Response Center
    • Annual Report
  • Industry Updates
    • Research & Policy Papers
    • Medtech POV with Scott Whitaker
    • Medtech POV Blog
    • Press Releases
  • Join
  • Member Center
    • Committees & Working Groups
    • Resource Library
    • Medtech Career Center
  • Events & Education
    • All Events & Education
    • In Person
    • Online
Login

Regulatory Affairs

Learn more about our Regulatory Affairs work.

Ethylene Oxide / Regulatory Affairs

AdvaMed® Comments on FDA Statement on Potential Device Shortages

WASHINGTON, D.C. – AdvaMed® released a statement on FDA’s announcement today that the agency is concerned about medical device shortages in light of two recent closures of ethylene oxide sterilization…

Ethylene Oxide / Regulatory Affairs

Nation’s Premier Surgeons Stress Importance of Ethylene Oxide for Medical Device Sterilization

WASHINGTON, D.C. – This week, six leading medical groups sent a letter to FDA urging caution as regulators consider limiting the use of ethylene oxide (EtO) for medical device sterilization. The surgeons…

cover of white paper
EMMA International logo
Regulatory Affairs

Quality Function Deployment (QFD) for Design Controls

This white paper covers the history and evolution of quality systems and their application to medical devices.

Regulatory Affairs

AdvaMed® Principles On Reprocessing Of Single Use Devices

Regulatory Affairs

Guiding Principles For Direct To Consumer Device Advertising

Diagnostics / Regulatory Affairs

AdvaMedDx® Letter to Sen. Alexander and Murray and Rep. Walden and Pallone

cover page of successful practices for battery powered medical devices
Regulatory Affairs

Successful Practices for Battery Powered Medical Devices

This document provides successful practices for the development, manufacture, and use of batteries in medical device applications

Regulatory Affairs

Principles Regarding The Use Of Real World Evidence (“RWE”) In The National Evaluation System For Health Technology (“NEST”) And Similar Systems

Regulatory Affairs

MDUFA Reauthorization Infographic

Diagnostics / Regulatory Affairs

Risk-Based Approach to Regulation of Diagnostics

  • Previous
  • 1
  • …
  • 13
  • 14
  • 15
  • Next
AdvaMed®

Stay up to date with AdvaMed®.

Subscribe for Updates
  • Join
  • Member Center
  • Industry Updates
  • Contact
  • FAQs
  • Events & Education
  • Careers
  • The Story of Medtech
  • The Medtech Conference
  • Because Every Moment Matters 

Copyright 2026 AdvaMed®

  • Sitemap
  • Terms of Use
  • Privacy Policy
  • Accessibility Statement
  • 中文
  • youtube
  • linkedin
  • facebook
  • X
  • medium
  • instagram

Menu

  • Our Work
    • Key Issues
    • Policy Areas
    • Sectors
    • Emerging Policy & Tariff Response Center
    • Annual Report
  • Industry Updates
    • Research & Policy Papers
    • Medtech POV with Scott Whitaker
    • Medtech POV Blog
    • Press Releases
  • Join
  • Member Center
    • Committees & Working Groups
    • Resource Library
    • Medtech Career Center
  • Events & Education
    • All Events & Education
    • In Person
    • Online
  • Login
  • About AdvaMed®
    • Our Leadership
    • Initiatives
    • Jobs at AdvaMed®
    • Contact Us
  • Membership & Join
    • Membership Directory
    • Associate Membership Directory
    • Membership Application
    • Lifetime Achievement Award
  • Medical Device Industry Facts
    • Safety & Quality
    • Job Creation
  • AdvaMed Accel®
    • Accel Member Directory
    • Partnerships and Opportunities
  • AdvaMedDx®
    • AdvaMed®DX Members
    • AdvaMedDx® Resources
    • Join AdvaMed®DX
  • AdvaMed Digital Health Tech™
    • AdvaMed Digital Health Tech™ Members
  • AdvaMed Medical Imaging™
    • AdvaMed Imaging® Members

Search